"Hemangiosarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
| Descriptor ID |
D006394
|
| MeSH Number(s) |
C04.557.450.795.390 C04.557.645.390
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hemangiosarcoma".
Below are MeSH descriptors whose meaning is more specific than "Hemangiosarcoma".
This graph shows the total number of publications written about "Hemangiosarcoma" by people in this website by year, and whether "Hemangiosarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 2 | 3 | 5 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 2000 | 0 | 1 | 1 |
| 2003 | 2 | 1 | 3 |
| 2004 | 0 | 1 | 1 |
| 2005 | 4 | 1 | 5 |
| 2006 | 2 | 0 | 2 |
| 2007 | 3 | 0 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 4 | 2 | 6 |
| 2010 | 6 | 1 | 7 |
| 2011 | 2 | 1 | 3 |
| 2012 | 3 | 0 | 3 |
| 2013 | 6 | 0 | 6 |
| 2014 | 6 | 1 | 7 |
| 2016 | 4 | 0 | 4 |
| 2017 | 8 | 1 | 9 |
| 2018 | 4 | 2 | 6 |
| 2019 | 6 | 0 | 6 |
| 2020 | 2 | 0 | 2 |
| 2021 | 3 | 0 | 3 |
| 2022 | 7 | 0 | 7 |
| 2023 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemangiosarcoma" by people in Profiles.
-
Primary epithelioid hemangioendotheliomas and angiosarcomas of the pleura: a clinicopathological and immunohistochemical analysis of 13 cases. Hum Pathol. 2023 08; 138:68-75.
-
Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy. Head Neck. 2023 Aug; 45(8):1943-1951.
-
Incidence, demographics, and survival of malignant hemangioendothelioma in the United States. Cancer Med. 2023 07; 12(14):15101-15106.
-
Breast Angiosarcoma: Imaging Features With Histopathologic Correlation. J Breast Imaging. 2023 May 22; 5(3):329-338.
-
Comparing Breast Hemangiomas to Breast Angiosarcomas: An Imaging Based Review. Curr Probl Diagn Radiol. 2023 May-Jun; 52(3):212-219.
-
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma. Cancer. 2022 10 01; 128(19):3516-3522.
-
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. Cancer. 2022 09 15; 128(18):3383-3391.
-
Management of Vascular Sarcoma. Surg Oncol Clin N Am. 2022 07; 31(3):485-510.
-
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial. JAMA Oncol. 2022 05 01; 8(5):740-747.
-
Cardiac Angiosarcomas: Risk of Brain Metastasis and Hemorrhage Warrants Frequent Surveillance Imaging and Early Intervention. Am J Clin Oncol. 2022 06 01; 45(6):258-263.